EX-3.(I)
from 10-Q
1 page
Certificate of Amendment to the Restated Certificate of Incorporation of Cytogen Corporation Cytogen Corporation, a Corporation Organized and Existing Under and by Virtue of the General Corporation Law of the State of Delaware (The "Corporation"), Does Hereby Certify as Follows: First: That the Board of Directors of the Corporation Adopted the Following Resolutions on May 5, 2005 With Respect to the Amendment and Restatement of Paragraph a of Article Fifth of the Corporation's Restated Certificate of Incorporation, as Amended (The "Charter Amendment"): Now, Therefore, Be It Resolved, That Paragraph a of Article Fifth of the Restated Certificate of Incorporation, as Amended, Be Amended in Its Entirety to Read as Follows: "Fifth: A. Total Capital Stock. the Total Number of Shares of All Classes of Capital Stock Which the Corporation Shall Have Authority to Issue Is Fifty-Five Million Four Hundred Thousand (55,400,000) Shares, of Which Fifty Million (50,000,000) Shall Be Shares of Common Stock, $.01 Par Value Per Share (The "Common Stock"); and Five Million Four Hundred Thousand (5,400,000) Shares Shall Be Preferred Stock, $.01 Par Value Per Share ("Preferred Stock")." Second: That Said Charter Amendment Was Duly Adopted by the Board of Directors and by the Stockholders of the Corporation in Accordance With the Provisions of Section 242 of the General Corporation Law of the State of Delaware. in Witness Whereof, the Corporation Has Caused This Certificate to Be Signed by Its Duly Elected President on This 15th Day of June, 2005. Cytogen Corporation By: /S/ Michael D. Becker Michael D. Becker President and Chief Executive Officer
12/34/56
